€100,000 in reward donations for projects fundraising to prevent atrial fibrillation-related strokes
23 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million announces its plans to support ongoing work in atrial fibrillation...
List view / Grid view
News
Boehringer Ingelheim announces positive phase II results for once-daily tiotropium in asthma
22 May 2012 | By Boehringer Ingelheim
Comprehensive Phase III UniTinA-asthma™ program ongoing...
View and listen to webcast of June 3 Pfizer analyst and investor meeting at ASCO
22 May 2012 | By Pfizer
View webcast of a presentation by Pfizer’s oncology leadership team...
Gerresheimer presents innovative Packaging concepts for the Latin and South American Pharma market
22 May 2012 | By Gerresheimer
Gerresheimer to present its entire portfolio of plastic pharmaceutical packaging products...
One million signatures needed to call upon WHO to save lives through education & improved management of AF
22 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million launches petition and unique fundraising platform...
Daiichi Sankyo and the National Cancer Center form comprehensive research alliance
22 May 2012 | By Daiichi Sankyo
This agreement is designed to integrate the high-level cancer research technology...
Lilly Diabetes presents Phase II blood pressure and heart rate data
22 May 2012 | By Eli Lilly and Company
Phase II trial used ambulatory blood pressure monitoring to evaluate blood pressure and heart rate for dulaglutide...
Boehringer Ingelheim’s once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD
21 May 2012 | By Boehringer Ingelheim
Olodaterol significantly improved lung function (FEV 1) for at least 24 hours compared to placebo...
Fast plasma sample cleanup with new Phree Phospholipid Removal Plates
21 May 2012 | By Phenomenex Inc
Phenomenex Inc., introduces Phree Phospholipid Removal Plates for fast cleanup of plasma samples...
FDA approves new labeling for ISENTRESS® (raltegravir)
21 May 2012 | By Merck
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
Capital increase in Lundbeck as a result of employee warrant programme
21 May 2012 | By H. Lundbeck A/S
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...
Two overall winners announced at prestigious national award ceremony in London’s Science Museum
18 May 2012 | By GlaxoSmithKline
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...
New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine
18 May 2012 | By Biogen Idec / Elan Corporation plc
Use of biomarker has potential to advance personalised treatment for MS patients...
NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN)
18 May 2012 | By Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...
Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
